Cambria Pharmaceuticals
is focused on discovering innovative treatments for serious and
progressively disabling neurological disorders. The company exploits recent discoveries
in the genetic basis of these disorders to engineer novel disease models and identify
first-in-class disease-modifying compounds. Cambria leverages collaborative relationships with academic institutions and patient-focused foundations to advance its programs in ALS (Lou Gehrig's disease) and other serious neurological diseases.
www.cambriapharma.com
Cambria Pharmaceuticals, Inc.
8A Henshaw St
Woburn, MA 01801
(781) 938-1333
For more information, please contact us